NEW YORK (GenomeWeb News) – Sengenics today said that it has entered into an exclusive agreement with the Sequenom Center for Molecular Medicine to launch and promote Sequenom's MaterniT21 Plus prenatal testing service in Malaysia and Singapore.

Sengenics will offer the test, which detects Trisomy 13, 18, and 21, to its partner Ob/Gyn clinicians and hospitals in the two countries. Sengenics is based in Kuala Lumpur and offers genomic-based diagnostic services. It added that it has contracts with eight of the top 10 private hospital chains in the region.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.

Apr
27
Sponsored by
SeraCare

This webinar is the third in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.